Nifty Pharma Today: Index Falls 1.26% in Opening Trade

Quick sector takeaways

• Nifty Pharma was down 1.26% in the early session on 1 September 2026, trading at 26,844.05, compared with its previous close of 27,186.45.
• The index had declined 342.40 points by 10:00:00 AM IST, after moving between 27,004.40 and 26,762.50 during the session.
• Market breadth was negative: 16 of 20 tracked pharma stocks declined, while four advanced and none were unchanged.
• JB Chemicals & Pharmaceuticals, Divi’s Laboratories, Ajanta Pharma and Torrent Pharmaceuticals were among the notable drags; Dr. Reddy’s Laboratories led the gainers. Watch whether the breadth improves from the opening trend.

Nifty Pharma today: early-session pressure builds

The nifty pharma today update reflects broad early-session pressure across the sector. Nifty Pharma stood at 26,844.05 at 10:00:00 AM IST, down 342.40 points, or 1.26%, from the previous close of 27,186.45. The index opened at 27,004.40 and remained below the previous closing level through the observed part of the session.

The decline was not confined to a small set of shares. With 16 stocks in the red out of 20 tracked names, the opening move showed widespread weakness across the index. Still, four gainers, led by Dr. Reddy’s Laboratories, showed that stock-specific price action remained varied within the sector.

Price snapshot

Nifty Pharma’s last traded price of 26,844.05 was 342.40 points below its previous close of 27,186.45. Its day high was 27,004.40, which was also its opening level, while the day low was 26,762.50. This placed the index 81.55 points above its intraday low at the time of the update and 160.35 points below the day’s high.

The intraday range of 241.90 points captures the trading band seen in the opening session. The index was trading in the lower part of that range, making its movement from the opening level and its ability to hold above the day’s low important observations as the session progresses.

Sector ranking

Nifty Pharma was the top losing sector index among the configured sector indices in this opening-bell snapshot. Its 1.26% fall was steeper than Nifty Bank’s 1.15% decline and Nifty Financial Services’ 1.14% fall. Nifty Mid Select also fell 1.14%, while Nifty IT was lower by 0.28%. In contrast, Nifty Auto, Nifty FMCG and Nifty Metal were trading higher.

This ranking places pharma at the weakest end of the selected sector-index set at 10:00:00 AM IST. It is a relative performance reading for the early session rather than a forecast of how the sector may trade later in the day.

Constituent breadth

The breadth picture aligned with the index decline. Sixteen of the 20 displayable stocks were decliners, against four advancers, producing an advance-decline ratio of 0.25. There were no unchanged stocks. In practical terms, there were four declining shares for every advancing share in this Nifty Pharma set.

Large falls in a few names and smaller losses across several others combined to keep the sector under pressure. The presence of four gainers limited the one-sidedness at the stock level, but the numerical balance continued to favour declines materially in the early session.

Heavyweights versus broader participation

Among the supplied heavyweight names, Sun Pharmaceutical Industries fell 2.07%, Divi’s Laboratories declined 2.97%, and Torrent Pharmaceuticals was lower by 2.57%. Cipla rose 0.27%, while Dr. Reddy’s Laboratories gained 1.48%.

The same five names also featured in the supplied active-stock set. Their mixed but predominantly negative moves were consistent with the broader breadth reading. The gains in Cipla and Dr. Reddy’s Laboratories offered selective positive participation, while the declines in Sun Pharma, Divi’s and Torrent Pharmaceuticals coincided with the index’s early weakness.

Key Nifty Pharma stocks

Biggest positive movers

Dr. Reddy’s Laboratories led the positive side with a 1.48% gain to ₹1,171.50. Gland Pharma rose 0.39% to ₹2,897.00 and Ipca Laboratories also added 0.39% to ₹1,982.70. Cipla gained 0.27% to ₹1,413.00. These advances showed selective resilience, though they were outnumbered by the sector’s decliners.

Biggest negative movers

JB Chemicals & Pharmaceuticals fell 3.87% to ₹2,408.90, followed by Divi’s Laboratories, down 2.97% to ₹9,186.00. Ajanta Pharma slipped 2.68% to ₹3,505.40, Torrent Pharmaceuticals fell 2.57% to ₹4,936.00, and Mankind Pharma declined 2.47% to ₹2,359.50. Each was trading above its respective intraday low at the recorded time, an observation that does not alter their negative day change.

Stocks to watch next session

Investors tracking the next session can keep JB Chemicals & Pharmaceuticals, Divi’s Laboratories, Ajanta Pharma, Torrent Pharmaceuticals, Sun Pharmaceutical Industries and Dr. Reddy’s Laboratories on watch. These names featured either among the strongest early declines, the supplied heavyweight set or the leading gainers. Their next-session moves can be read alongside the sector’s breadth and index range rather than in isolation.

The constructive case

The constructive evidence in this early update lies in the presence of four advancing stocks despite the sector-wide decline. Dr. Reddy’s Laboratories gained 1.48%, while Gland Pharma, Ipca Laboratories and Cipla were also positive. Nifty Pharma was also 81.55 points above its intraday low at the recorded time, indicating that it was not at the session low in this snapshot.

A later improvement in the number of advancing stocks, together with a move away from the lower end of the day’s range, would be a constructive development to monitor. These are market observations, not directional calls.

The cautious case

The cautious case is defined by the scale and breadth of the early fall. Nifty Pharma was down 1.26%, the weakest among the configured sector indices, and 16 of 20 tracked stocks were lower. The day high matched the opening level, while the index subsequently moved lower into a 26,762.50 to 27,004.40 range.

Losses of more than 2% in JB Chemicals & Pharmaceuticals, Divi’s Laboratories, Ajanta Pharma, Torrent Pharmaceuticals, Mankind Pharma, Laurus Labs and Sun Pharmaceutical Industries reinforced the negative participation. Whether the index can move away from the lower portion of its early range and whether the advance-decline balance changes remain the key measurable signals.

Univest Insights

At the opening bell, nifty pharma today is defined by a 342.40-point fall from the prior close and negative stock breadth. The index’s level of 26,844.05 provides the current sector reference point, while 27,004.40 and 26,762.50 frame the observed early-session range.

For market participants, the distinction between broad participation and isolated stock moves is especially relevant here. Four shares were positive, but the 16-to-four decline-to-advance split shows that the sector move had wide participation rather than being limited to one or two stocks.

The largest percentage losers and the supplied heavyweight names were mostly on the negative side, while Dr. Reddy’s Laboratories and Cipla provided positive counterpoints among heavyweight stocks. Readers can follow the sector page and the Univest Market View for the evolving market context.

For traders and investors, the key signal to watch is…

Published on 1 September 2026 at 10:03 AM IST

Frequently asked questions

What is Nifty Pharma today?

Nifty Pharma was at 26,844.05 at 10:00:00 AM IST on 1 September 2026, down 342.40 points or 1.26% from 27,186.45.

Why was Nifty Pharma the top losing sector index?

Its 1.26% decline was the largest fall among the configured sector indices in this early-session snapshot.

What was Nifty Pharma’s intraday range?

The index traded between a day high of 27,004.40 and a day low of 26,762.50.

How was the breadth in Nifty Pharma?

Of 20 displayable stocks, 16 declined and four advanced, with no unchanged stocks.

Which stocks gained in Nifty Pharma?

Dr. Reddy’s Laboratories led with a 1.48% rise. Gland Pharma, Ipca Laboratories and Cipla also traded higher.

Which stocks were the major losers?

JB Chemicals & Pharmaceuticals, Divi’s Laboratories, Ajanta Pharma, Torrent Pharmaceuticals and Mankind Pharma were the leading supplied decliners.